• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Tuesday, November 17, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Chemistry

Structural Mapping Resolves Critical Protein Knowledge Gaps in Leprosy Pathogen Biology

by
November 17, 2026
in Chemistry
Reading Time: 6 mins read
0
Structural Mapping Resolves Critical Protein Knowledge Gaps in Leprosy Pathogen Biology

Structural Mapping Resolves Critical Protein Knowledge Gaps in Leprosy Pathogen Biology

Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

A comprehensive mini-review examining 52 published studies reveals that structural biology and artificial intelligence-based predictive modeling are beginning to illuminate the molecular machinery of Mycobacterium leprae, the primary causative organism of leprosy, despite persistent experimental hurdles. Published in Frontiers in Chemistry by researchers from the Kenya Institute of Primate Research, the synthesis demonstrates that while leprosy remains a persistent global public health issue with over 200,000 newly reported clinical infections each year, structural characterisation of the bacillus has lagged drastically behind other major pathogens. More than two to three million individuals worldwide live with long-term disabilities resulting from chronic infection of the skin, peripheral nerves, and mucosal tissues. To overcome decades of experimental bottlenecks stemming from the organism’s extreme reductive genome evolution and inability to grow in artificial laboratory media, investigators are increasingly leveraging structural determination, homology modeling, and machine learning to map critical drug targets, decipher antimicrobial resistance mutations, and accelerate structure-guided therapeutic interventions.

Understanding the basic physiology and pathogenic mechanisms of Mycobacterium leprae has long represented one of the most demanding challenges in modern microbiology. The bacterium is an obligate intracellular pathogen characterized by an exceptionally sluggish replication rate, with a doubling time estimated at approximately 12 to 14 days. Because it cannot be propagated in conventional cell-free in vitro cultures, biological and pharmacological studies have historically depended upon specialized animal models, predominantly mouse footpads and nine-banded armadillos, which fundamentally limits high-throughput laboratory experimentation. Furthermore, comparative genomic analyses demonstrate that extensive evolutionary decay has stripped the organism of numerous metabolic cascades, leaving a compact genome with only 1,614 annotated protein-coding genes alongside hundreds of non-functional pseudogenes. These evolutionary constraints have hindered traditional microbiological assays, making structural elucidation and computational simulation vital avenues for deciphering how the pathogen survives within host tissues and resists existing therapeutic regimens.

The review identifies an enormous structural knowledge deficit when comparing Mycobacterium leprae to its close relative Mycobacterium tuberculosis. Although approximately 1,600 protein-coding genes are expressed across the bacterium’s genome, the Protein Data Bank contained experimentally resolved three-dimensional coordinates for only around 17 proteins at the time of initial comprehensive surveys, with an updated preprint cataloging just 10 distinct deposition entries representing seven unique proteins across 1,603 protein-coding open reading frames. In stark contrast, the Protein Data Bank contains approximately 1,277 structural entries for Mycobacterium tuberculosis. This pronounced disparity severely restricts direct mechanistic interpretation of protein function, active-site dynamics, and drug-target interactions, often forcing researchers to extrapolate functional hypotheses from distant homologs. Compounding this challenge, current public health regimens rely on multi-drug therapy comprising rifampicin, dapsone, and clofazimine administered over prolonged durations of six to twelve months, a framework increasingly threatened by clinical resistance mutations emerging in the rpoB, folP1, and gyrA genes.

Despite historical difficulties, targeted X-ray crystallography has successfully captured the high-resolution architecture of several key metabolic enzymes operating within Mycobacterium leprae. Among these, the crystal structure of phosphoglycerate mutase Gpm1, determined at 2.45 angstrom resolution under Protein Data Bank identifier 4EO9, confirmed the conserved fold responsible for glycolytic catalysis. Structural studies have also resolved the riboflavin biosynthesis enzyme RibH at 1.95 angstroms as a conserved pentameric assembly, inorganic pyrophosphatase PPA at 1.80 angstroms, and cytidine deaminase Cdd at 2.30 angstroms, which plays a central role in nucleotide metabolism. Additionally, the 2.10 angstrom structure of GlcB established the three-dimensional architecture of malate synthase G within the glyoxylate shunt, an alternate pathway for carbon utilization. While these crystallographic models define specific catalytic sites, binding cavities, and oligomeric states, the authors emphasize that structural coordinates alone cannot demonstrate whether these metabolic enzymes directly govern bacterial survival or persistence inside human hosts without corroborating biochemical data.

X-ray diffraction studies have also provided structural blueprints for proteins dedicated to maintaining genomic stability and mediating cellular stress responses under physiological hardship. The co-chaperonin Cpn10 was resolved at 3.5 angstrom resolution, revealing a characteristic heptameric dome-shaped assembly that interacts with the larger Cpn60 chaperonin machinery to orchestrate protein folding. Genome preservation mechanisms are further illuminated by structures of single-stranded DNA-binding protein SSB, determined at 2.05 and 2.80 angstrom resolutions, which display conserved oligonucleotide-binding folds essential for stabilising single-stranded DNA intermediates. Similarly, the crystal structure of RuvA resolved at 2.38 angstroms depicts an octameric complex bound to a synthetic Holliday junction, providing structural verification of its participation in homologous recombination and DNA repair. Other stress-associated proteins, such as the conserved hypothetical protein ML1485 resolved at 2.30 angstroms, demonstrate a thioredoxin-like fold indicative of redox-regulatory functions, although its definitive cellular substrates remain unverified experimentally.

Structure-based drug discovery has gained momentum as researchers apply computational docking, homology modeling, and virtual screening to bypass the limitations of physical bacterial culturing. Dihydropteroate synthase, encoded by folP1 or ML0224, represents the primary enzymatic target of dapsone. Because FolP1 lacked an experimental crystal structure, researchers constructed three-dimensional homology models and performed molecular docking to investigate how dapsone engages the active pocket, successfully mapping how known clinical resistance mutations physically disrupt drug binding. Homology modeling has likewise been applied to homoserine dehydrogenase from the TN strain, where virtual screening identified candidate inhibitors displaying favorable binding scores within the predicted pocket. However, because these inhibitor discoveries rely entirely on computational docking within modeled binding sites rather than empirical assays, the identified molecules remain theoretical candidates awaiting direct biochemical confirmation of enzyme inhibition and verified bactericidal activity against whole organisms.

A major structural milestone highlighted in the review involves ML2640c, an S-adenosylmethionine-dependent methyltransferase from Mycobacterium leprae for which authentic crystallographic coordinates have been resolved at 1.80 angstrom resolution. This experimentally determined template provides an exceptionally solid foundation for structure-based drug screening compared to unverified homology predictions. Recent virtual screening campaigns evaluated 2,895 marine-derived natural products from the Comprehensive Marine Natural Products Database against the ML2640c binding pocket. Investigators identified three top candidate compounds, designated CMNPD24471, CMNPD25830, and CMNPD21066, which yielded favorable docking scores between minus 11.2 and minus 11.5 kilocalories per mole compared to minus 7.8 kilocalories per mole for the natural cofactor S-adenosylmethionine. Molecular dynamics trajectories, principal component analysis, and free-energy landscape evaluations confirmed that CMNPD24471 formed highly stable hydrogen bonds with pocket residues Ala110, Leu113, and Gln250 alongside multiple hydrophobic contacts, generating 30 optimized chemical analogues through computational scaffold hopping.

The integration of advanced artificial intelligence systems has fundamentally reshaped structural coverage across the entire proteome of Mycobacterium leprae. The recently established HANSEN resource deployed contemporary deep-learning algorithms, including AlphaFold 3 and Boltz-1, to construct three-dimensional structural models for 1,603 proteins encoded within the pathogen’s reduced proteome. Systematic geometric cavity detection across these models has allowed researchers to locate previously hidden ligand-binding pockets and map documented antimicrobial resistance mutations directly onto predicted protein architectures. AI-guided modeling has also unraveled uncharacterized proteins, such as the hypothetical protein ML0099. Structural prediction using AlphaFold 3 and deepTHMM assigned ML0099 to the CULP lipolytic family, identifying a conserved GxSxG pentapeptide motif and a putative catalytic triad of Ser175, Asp268, and His299. Subsequent virtual screening of approximately 3,600 approved pharmaceutical agents identified zileuton and glipizide as potential binders with docking energies between minus 8.5 and minus 9.1 kilocalories per mole.

Computational pipelines are similarly accelerating drug repurposing and candidate lead identification across lipid synthesis enzymes and central carbon pathways. Virtual screening of 1,147 plant-derived phytochemicals against enoyl-acyl carrier protein reductase InhA, a critical component of mycolic acid biosynthesis, prioritised hinokiflavone, 3,29-dibenzoyl rarounitriol, and 4-prime-O-methylochnaflavone. These compounds achieved docking scores ranging from minus 12.2 to minus 12.7 kilocalories per mole, outperforming the reference ligand, while 500-nanosecond molecular dynamics simulations and machine-learning quantitative structure-activity relationship models predicted pIC50 potencies between 7.373 and 7.494. In parallel repurposing evaluations targeting the modeled LipU lipase, approved therapeutics including digoxin, indinavir, and travoprost demonstrated stable simulated binding. Furthermore, the antiretroviral drugs tenofovir, emtricitabine, and lamivudine were docked against an energy-minimised crystal structure of Gpm1, with tenofovir achieving a docking score of minus 37.7297 kilocalories per mole, though none of these repurposed molecules have yet been proven to arrest bacterial proliferation in laboratory assays.

Translating these structural findings into clinical interventions also extends to rational vaccine development and host-directed immunotherapy. While the widely administered Bacillus Calmette-Guerin vaccine confers partial, variable cross-protection against leprosy, no dedicated vaccine tailored specifically for Mycobacterium leprae is currently deployed for widespread global clinical use. Candidates such as the non-pathogenic Mycobacterium indicus pranii vaccine have demonstrated therapeutic and prophylactic potential, but defined subunit formulations like LepVax rely directly on structural biology to identify surface-exposed conformational epitopes and stable antigen interfaces. Concurrently, host-directed agents like thalidomide remain vital for managing severe inflammatory complications such as erythema nodosum leprosum by modulating tumor necrosis factor-alpha. The review concludes that while computational structural biology provides an unprecedented hypothesis-generating framework, the field must now bridge the translational divide by uniting in silico predictions with rigorous biochemical assays, site-directed mutagenesis, and animal infection models to achieve lasting disease elimination.

Subject of Research: Structural characterisation and computational drug discovery in Mycobacterium leprae

Article Title: Structural mapping of Mycobacterium leprae to understand pathogenesis and advance therapeutic discovery; a mini review

Article References: Irungu, S., Ngalla, L. M., Fafali, M. M., Imbahale, L. C., Kimani, C. N., & Jillani, N. (2026). Structural mapping of Mycobacterium leprae to understand pathogenesis and advance therapeutic discovery; a mini review. Frontiers in Chemistry, 14, Article 1954624. https://doi.org/10.3389/fchem.2026.1954624

Image Credits: AI Generated

DOI: 10.3389/fchem.2026.1954624

Keywords: Mycobacterium leprae, leprosy, structural biology, Hansen's disease, protein data bank, AlphaFold 3, HANSEN resource, FolP1, dapsone resistance, Gpm1, ML2640c, structure-based drug discovery, molecular docking, molecular dynamics, InhA, LepVax, reductive evolution, mycolic acid biosynthesis

News Source: Kristina Jarvis. (November 17, 2026). Structural Mapping Resolves Critical Protein Knowledge Gaps in Leprosy Pathogen Biology. Scienmag.

Tags: AlphaFold 3dapsone resistanceFolP1Gpm1HANSEN resourceHansen's diseaseInhAleprosyLepVaxML2640cmolecular dockingmolecular dynamicsMycobacterium lepraemycolic acid biosynthesisProtein Data Bankreductive evolutionstructural biologystructure-based drug discovery
Share12Tweet7Share2ShareShareShare1

Related Posts

Quantum Tunneling Restores Essential Electrons to Diamond Defects for Quantum Devices

Quantum Tunneling Restores Essential Electrons to Diamond Defects for Quantum Devices

November 17, 2026
Carbon-Activated Persulfate Eliminates Bisphenol A From Groundwater Across Broad Chemical Conditions

Carbon-Activated Persulfate Eliminates Bisphenol A From Groundwater Across Broad Chemical Conditions

November 17, 2026

Resorcinol Ionization in Organic Solvents Follows First-Order Kinetics and Increases with Temperature

November 17, 2026

Helichrysum Bracteatum Flavonoid Extraction Yields Potent In Vitro and In Silico Antioxidants

November 17, 2026

POPULAR NEWS

  • City of Hope, Adagene Launch Trial Testing Combination Immunotherapy for Colorectal Cancer

    City of Hope, Adagene Launch Trial Testing Combination Immunotherapy for Colorectal Cancer

    29 shares
    Share 12 Tweet 7
  • Repetitive Mild Brain Injury Triggers Chronic Cerebrovascular Inflammation and Glymphatic Suppression

    29 shares
    Share 12 Tweet 7
  • Durable Remission in Advanced Squamous-Cell Lung Cancer Following Sodium Selenite Treatment

    29 shares
    Share 12 Tweet 7
  • Circulating tRNA Fragments Distinguish Endometriosis Patients in Preliminary Pilot Study

    29 shares
    Share 12 Tweet 7

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

High-Resolution Imaging Captures Dynamic Ovulation and Oocyte Transport in Live Mice

China Green Finance Drives Grain Output Growth Without Reducing Agricultural Water Use

Inhibiting miR-339-3p Eases Sevoflurane-Linked Cognitive Deficits in Aged Rats

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 88 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.